BRPI0509878A - ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária - Google Patents
ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronáriaInfo
- Publication number
- BRPI0509878A BRPI0509878A BRPI0509878-5A BRPI0509878A BRPI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A BR PI0509878 A BRPI0509878 A BR PI0509878A
- Authority
- BR
- Brazil
- Prior art keywords
- depression
- patients
- prevention
- treatment
- heart disease
- Prior art date
Links
- 208000029078 coronary artery disease Diseases 0.000 title abstract 4
- 208000020401 Depressive disease Diseases 0.000 title abstract 3
- 235000004626 essential fatty acids Nutrition 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 210000004351 coronary vessel Anatomy 0.000 title 1
- 208000019622 heart disease Diseases 0.000 title 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 2
- 200000000007 Arterial disease Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 abstract 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 abstract 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 229940013317 fish oils Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04101578 | 2004-04-16 | ||
| PCT/EP2005/004031 WO2005110393A1 (en) | 2004-04-16 | 2005-04-15 | Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0509878A true BRPI0509878A (pt) | 2007-10-16 |
Family
ID=34928968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0509878-5A BRPI0509878A (pt) | 2004-04-16 | 2005-04-15 | ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1765319A1 (https=) |
| JP (1) | JP2007532605A (https=) |
| CN (1) | CN1942180A (https=) |
| AU (1) | AU2005244483B2 (https=) |
| BR (1) | BRPI0509878A (https=) |
| CA (1) | CA2504280A1 (https=) |
| IL (1) | IL178300A0 (https=) |
| MX (1) | MX291518B (https=) |
| RU (1) | RU2387448C2 (https=) |
| UA (1) | UA94693C2 (https=) |
| WO (1) | WO2005110393A1 (https=) |
| ZA (1) | ZA200607794B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2421909A (en) * | 2004-12-23 | 2006-07-12 | Laxdale Ltd | Pharmaceutical compositions comprising EPA and methods of use |
| ITMI20100961A1 (it) * | 2010-05-27 | 2011-11-28 | Erredue Spa | Miscele ricche in esteri di acidi grassi omega-3, loro composizioni e loro processo di preparazione |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998048788A1 (en) * | 1997-04-29 | 1998-11-05 | Scotia Holdings Plc | Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants |
| IT1308613B1 (it) * | 1999-02-17 | 2002-01-09 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella prevenzione di eventi cardiovascolari. |
| GB9916536D0 (en) * | 1999-07-14 | 1999-09-15 | Scarista Limited | Nutritional or pharmaceutical compositions |
| ATE291910T1 (de) * | 2001-05-30 | 2005-04-15 | Laxdale Ltd | Verwendung von coenzym q (ubiquinone) und eikosapentaensäure (epa) für die behandlung von non-hodgkin's lymphoma und psychiatrischen oder neurologischen erkrankungen |
-
2005
- 2005-04-15 ZA ZA200607794A patent/ZA200607794B/en unknown
- 2005-04-15 JP JP2007507767A patent/JP2007532605A/ja active Pending
- 2005-04-15 BR BRPI0509878-5A patent/BRPI0509878A/pt not_active IP Right Cessation
- 2005-04-15 UA UAA200611798A patent/UA94693C2/ru unknown
- 2005-04-15 CA CA002504280A patent/CA2504280A1/en not_active Abandoned
- 2005-04-15 WO PCT/EP2005/004031 patent/WO2005110393A1/en not_active Ceased
- 2005-04-15 MX MXPA06011940 patent/MX291518B/es active IP Right Grant
- 2005-04-15 RU RU2006140277/14A patent/RU2387448C2/ru not_active IP Right Cessation
- 2005-04-15 AU AU2005244483A patent/AU2005244483B2/en not_active Ceased
- 2005-04-15 EP EP05779398A patent/EP1765319A1/en not_active Withdrawn
- 2005-04-15 CN CNA2005800114285A patent/CN1942180A/zh active Pending
-
2006
- 2006-09-26 IL IL178300A patent/IL178300A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA94693C2 (ru) | 2011-06-10 |
| CN1942180A (zh) | 2007-04-04 |
| AU2005244483A1 (en) | 2005-11-24 |
| RU2387448C2 (ru) | 2010-04-27 |
| CA2504280A1 (en) | 2005-10-16 |
| MX291518B (es) | 2011-10-31 |
| JP2007532605A (ja) | 2007-11-15 |
| RU2006140277A (ru) | 2008-05-27 |
| ZA200607794B (en) | 2008-05-28 |
| WO2005110393A1 (en) | 2005-11-24 |
| IL178300A0 (en) | 2007-02-11 |
| AU2005244483B2 (en) | 2011-06-09 |
| MXPA06011940A (es) | 2006-12-15 |
| EP1765319A1 (en) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Singer et al. | Slow desaturation and elongation of linoleic and α-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects | |
| Stillwell et al. | Docosahexaenoic acid: membrane properties of a unique fatty acid | |
| Mozaffarian et al. | (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? | |
| Horrobin et al. | Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding | |
| EA200300830A1 (ru) | Незаменимые n-3 жирные кислоты в лечении сердечной недостаточности и сердечной декомпенсации | |
| Gogus et al. | n-3 Omega fatty acids: a review of current knowledge | |
| DE60000133C5 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
| US20080113046A1 (en) | Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients | |
| TR201908522T4 (tr) | Kan lipidi düşürücü maddeler olarak keton gövdeleri ve keton gövde esterleri. | |
| BRPI0518398A2 (pt) | Ácidos graxos âmega-3 e agente deslipidÊmico para terapia de lipÍdeos | |
| WO2007103160A3 (en) | Stearidonic acid for improving cardiovascular health | |
| WO2009091538A3 (en) | Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia | |
| JPS60115522A (ja) | 血中のコレステロ−ル及びトリグリセリドのレベルを低下させるための複合脂肪酸組成物 | |
| AR062305A1 (es) | Metodos para mejorar la salud osea y la salud muscular | |
| Shahidi | Omega-3 fatty acids and marine oils in cardiovascular and general health: A critical overview of controversies and realities | |
| MA30584B1 (fr) | Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires | |
| IL192366A (en) | Omega 3 fatty acid formulations | |
| JP2008050367A5 (https=) | ||
| Radcliffe et al. | Controversies in omega-3 efficacy and novel concepts for application | |
| Harrison et al. | The mechanism of action of omega-3 fatty acids in secondary prevention post-myocardial infarction | |
| ATE424732T1 (de) | Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate | |
| BRPI0509878A (pt) | ácidos graxos essenciais na prevenção e/ou tratamento da depressão em doentes com doença arterial ou cardìaca coronária | |
| WO2006111633A3 (fr) | Utilisation de la lecithine comme medicament dans le traitement du psoriasis | |
| NO20014341L (no) | Opplösning av flerumettede fettsyrer og derivater derav ved dannelse av inklusjonssammensetninger med <gamma>-syklodekstrin ogbruk derav i farmasöytiske, kosmetiske eller matsammensetninger | |
| WO1998057628A1 (fr) | Composition capable de supprimer le facteur de risque pendant l'exercice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: ABBOTT PRODUCTS GMBH (DE) |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015. |